Kotaro Hatta, MD, PhD
- 2Articles
- 31.5KReads
- 2017–2019Active
- 22Collaborators
- 161Citations
About
Kotaro Hatta, MD, PhD, has published research on the prevention of delirium, focusing on the use of ramelteon and suvorexant in patients with risk factors for this condition. The work includes clinical trials assessing the efficacy of suvorexant in delirium prevention. Hatta's contributions are grounded in neurology and have appeared in Psychiatrist.com between 2017 and 2019.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
